GSK (GSK) News Today GBX 1,395.50 +12.50 (+0.90%) As of 12:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesSustainabilityBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period GSK wins settlement, future royalties in CureVac mRNA patent disputeAugust 8 at 8:45 AM | lse.co.ukGSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settledAugust 8 at 8:45 AM | msn.comGSK to be paid up to £370 million after patent row settles in USAugust 8 at 8:45 AM | msn.comCureVac and GSK settle mRNA patent dispute with Pfizer and BioNTechAugust 8 at 8:45 AM | msn.comLONDON BRIEFING: GSK wins settlement payout; FBD interim profit halvesAugust 8 at 3:45 AM | lse.co.ukGSK’s New Study on GSK5764227: A Potential Game-Changer in Gastrointestinal Cancer TreatmentAugust 8 at 3:45 AM | msn.comPfizer, BioNTech Reach Covid Jab Settlement With GSK, CureVacAugust 8 at 3:45 AM | barrons.comJPMorgan Chase & Co. Issues Pessimistic Forecast for GSK (LON:GSK) Stock PriceAugust 6 at 2:03 AM | americanbankingnews.comJPMorgan Chase & Co. Lowers GSK (LON:GSK) Price Target to GBX 1,400August 5 at 7:25 AM | marketbeat.comGSK's (GSK) "Hold" Rating Reiterated at Deutsche Bank AktiengesellschaftAugust 1, 2025 | marketbeat.comGSK (LON:GSK) Announces Earnings ResultsJuly 31, 2025 | marketbeat.comGSK slips Thursday, underperforms marketJuly 31, 2025 | marketwatch.comGSK (LON:GSK) Receives "Buy" Rating from Shore CapitalJuly 31, 2025 | marketbeat.comGSK Positive on Outlook as HIV Drugs, Vaccines Spur GrowthJuly 30, 2025 | msn.comGSK in talks with U.S. to lower drug pricesJuly 30, 2025 | msn.comGSK advances Wednesday, outperforms marketJuly 30, 2025 | marketwatch.comGSK expects sales, profit toward top of 2025 forecasts despite tariff, pipeline pressuresJuly 30, 2025 | msn.comGSK reports improved outlook despite US drug tariffsJuly 30, 2025 | msn.comGSK lifts 2025 forecast after profit jumps on strong HIV, cancer drug salesJuly 30, 2025 | za.investing.comGSK eyes top-end annual results as second quarter beats expectationsJuly 30, 2025 | lse.co.ukGSK Upbeat on Guidance After Specialty Medicines Boost SalesJuly 30, 2025 | msn.comGSK expects sales and profit at top end of forecast range after second-quarter beatJuly 30, 2025 | msn.comGSK boosts annual growth outlook as second-quarter profit beats forecastsJuly 30, 2025 | msn.comGSK’s Profit Outshines Estimates as Vaccines Keep GrowingJuly 30, 2025 | msn.comGSK strikes £370m deal with Chinese rival Jiangsu Hengrui to develop up to a dozen new medicinesJuly 28, 2025 | msn.comLONDON BRIEFING: GSK in USD12 billion drug portfolio deal with HengruiJuly 28, 2025 | lse.co.ukHengrui Pharma: Entered Into Agreements With GSK to Develop Up to 12 Innovative Medicines >1276.HKJuly 27, 2025 | marketwatch.comGSK hails EU approval for blood cancer drug as US regulator waversJuly 25, 2025 | lse.co.ukGSK rallies Thursday, outperforms marketJuly 24, 2025 | marketwatch.comGSK wins EU approval for drug combos containing blood cancer drug BlenrepJuly 24, 2025 | msn.comGSK's blood cancer drug gets EU approvalJuly 24, 2025 | msn.comGSK blood cancer drug reapproved by EU regulatorJuly 24, 2025 | ft.comBiotech firm to lay off 150 people in Cambridge, move manufacturing to Penn.July 21, 2025 | msn.comGSK (LON:GSK) Earns "Hold" Rating from Deutsche Bank AktiengesellschaftJuly 21, 2025 | marketbeat.comGSK Blood Cancer Drug Blenrep Fails to Win FDA Panel SupportJuly 19, 2025 | msn.comGSK blood cancer drug fails to win backing of key US regulatory panelJuly 19, 2025 | ft.comGSK's blood cancer drug fails to secure US FDA advisers' supportJuly 19, 2025 | msn.comBofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510July 18, 2025 | insidermonkey.comGSK (LON:GSK) Earns Buy Rating from Shore CapitalJuly 18, 2025 | marketbeat.comBerenberg Bank Reiterates "Hold" Rating for GSK (LON:GSK)July 18, 2025 | marketbeat.comGSK's (GSK) "Underweight" Rating Reaffirmed at JPMorgan Chase & Co.July 18, 2025 | marketbeat.comGSK wins FDA nod for new shingles vaccine formatJuly 17, 2025 | msn.comGSK wins US approval for prefilled syringe version of shingles vaccineJuly 17, 2025 | lse.co.ukGSK (LON:GSK) Shares Pass Above Two Hundred Day Moving Average - Here's What HappenedJuly 16, 2025 | marketbeat.comFDA flags safety concerns related to GSK’s blood cancer drug ahead of AdCom meetingJuly 15, 2025 | msn.comGSK Executives Acquire Shares Following Dividend ReinvestmentJuly 15, 2025 | tipranks.comZantac makers handed court win in DelawareJuly 11, 2025 | msn.comGSK Stock Gains As Flu Vaccine Rollout Begins And US Recovers From Most Severe Season In 15 YearsJuly 11, 2025 | msn.comGSK Enhances Shareholder Value with Strategic BuybackJuly 10, 2025 | tipranks.comGSK (LON:GSK) Stock Price Crosses Below Two Hundred Day Moving Average - Should You Sell?July 1, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼-0.030.38▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼106▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today ITH News Today HCM News Today INDV News Today GRI News Today BMY News Today OGN News Today GPH News Today IGC News Today AURA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.